Variant report
Variant | nsv428618 |
---|---|
Chromosome Location | chr14:20500951-20660726 |
allele | n/a |
Outlinks | Ensembl   UCSC |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr14:20502200-20502400 | Enhancers | Pancreas | Pancrea |
2 | chr14:20502400-20504200 | Weak transcription | Pancreas | Pancrea |
3 | chr14:20512200-20512400 | Enhancers | K562 | blood |
4 | chr14:20512400-20512800 | Flanking Active TSS | K562 | blood |
5 | chr14:20512800-20513200 | Enhancers | K562 | blood |
6 | chr14:20513200-20515800 | Weak transcription | K562 | blood |
7 | chr14:20514600-20515000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
8 | chr14:20515000-20517000 | ZNF genes & repeats | HUES64 Cell Line | embryonic stem cell |
9 | chr14:20515800-20517600 | Enhancers | K562 | blood |
10 | chr14:20520400-20521400 | ZNF genes & repeats | HUES48 Cell Line | embryonic stem cell |
11 | chr14:20533000-20533400 | ZNF genes & repeats | HUES48 Cell Line | embryonic stem cell |
12 | chr14:20542800-20543400 | Active TSS | Fetal Heart | heart |
13 | chr14:20561600-20562000 | Enhancers | Primary neutrophils fromperipheralblood | blood |
14 | chr14:20574400-20574600 | Enhancers | Pancreatic Islets | Pancreatic Islet |
15 | chr14:20580400-20580800 | Enhancers | K562 | blood |
16 | chr14:20580800-20584200 | Weak transcription | K562 | blood |
17 | chr14:20584200-20584600 | Enhancers | K562 | blood |
18 | chr14:20584600-20585000 | Flanking Active TSS | K562 | blood |
19 | chr14:20585000-20585200 | Enhancers | K562 | blood |
20 | chr14:20585200-20585400 | Flanking Active TSS | K562 | blood |
21 | chr14:20585400-20585600 | Enhancers | K562 | blood |
22 | chr14:20585400-20585800 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
23 | chr14:20585600-20585800 | ZNF genes & repeats | K562 | blood |
24 | chr14:20585800-20586400 | Genic enhancers | K562 | blood |
25 | chr14:20586200-20586600 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
26 | chr14:20586400-20586600 | Enhancers | K562 | blood |
27 | chr14:20611200-20612600 | Enhancers | K562 | blood |
28 | chr14:20612400-20612800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
29 | chr14:20613200-20613400 | Enhancers | Pancreatic Islets | Pancreatic Islet |
30 | chr14:20613600-20621000 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
31 | chr14:20622200-20622400 | Enhancers | Pancreatic Islets | Pancreatic Islet |
32 | chr14:20623000-20624000 | ZNF genes & repeats | HUES64 Cell Line | embryonic stem cell |
33 | chr14:20630600-20630800 | ZNF genes & repeats | Pancreas | Pancrea |
34 | chr14:20638000-20638800 | Enhancers | K562 | blood |
35 | chr14:20638400-20638600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
36 | chr14:20638400-20638800 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
37 | chr14:20638800-20643000 | Weak transcription | K562 | blood |
38 | chr14:20643000-20644000 | Enhancers | K562 | blood |
39 | chr14:20643400-20643600 | Enhancers | Pancreas | Pancrea |
40 | chr14:20643400-20643800 | Enhancers | Stomach Mucosa | stomach |
41 | chr14:20643800-20645200 | Weak transcription | Pancreas | Pancrea |
42 | chr14:20644000-20644200 | Flanking Active TSS | K562 | blood |
43 | chr14:20644200-20644400 | Enhancers | Stomach Mucosa | stomach |
44 | chr14:20644200-20644600 | Enhancers | K562 | blood |
45 | chr14:20644600-20644800 | Flanking Active TSS | K562 | blood |
46 | chr14:20644800-20645000 | Enhancers | K562 | blood |
47 | chr14:20645000-20645200 | Flanking Active TSS | K562 | blood |
48 | chr14:20645200-20645800 | Enhancers | K562 | blood |
49 | chr14:20645200-20646400 | Enhancers | Pancreas | Pancrea |
50 | chr14:20645800-20646400 | Flanking Active TSS | K562 | blood |